image 2 image 4
Skip Navigation Links
 Home 
 Congress Structure 
 Important Dates 
 Venue 
 Pre Registered 
 Hotel Info 
 Abstracts 
 Scientific Program 
 Social Program 
 Exhibition 
 Contact Us 
 Archive 
       XXIII Annual Congress of the Iranian Society of Ophthalmology        بـیــست و سومین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
مقاله Abstract


Title: Complications of Retinal Vein Occlusions : effect of intravitreal injection of bevacizumab.
Author(s): Touka Banaee,Dariush Farrokh Tehrani, Atefeh Shahroodi.
Presentation Type: Oral
Subject: Posterior Segment
Others:
Presenting Author:
Name: Touka Banaee
Affiliation :(optional) Retina Research Center, Mashhad University of Medical Sciences
E mail: banaeet@mums.ac.ir
Phone: 7638577
Mobile: 09153100045
Purpose:

To report the complications of various types of RVO and their difference between patients with and without history IVB injection.

Methods:

Retrospective study.

Results:

110 patients were included: 41 ischemic CRVO, 25 non-ischemic CRVO, and 44 BRVO cases, followed for 8-36 months and mean age of 59.24±14.75. Sixty patients had history of IVB (mean: 1.8). Macular edema (70%), vitreous hemorrhage (26%), and neovascular glaucoma (19.3%) were the most common complications. There were no differences in complications between various types of RVO except for less vitreous hemorrhage (p=0.017) and more neovascular glaucoma (p=0.015) in ischemic CRVO. Injection caused reduction in macular edema in all types of RVO (p<0.05). Neovascular complications increased during the study period in eyes with ischemic (p= 0.014) and non-ischemic (p=0.046) CRVO without history of IVB but not in those with history of IVB (p>0.05). IOP and VA were not different between various types of RVO and between patients with or without injection.

Conclusion:

Eyes with ischemic CRVO more commonly developed neovascular glaucoma and less commonly developed vitreous hemorrhage. Bevacizumab injection caused a decrease in macular edema in all types of RVO, which was not accompanied by an increase in visual acuity. Injection also prevented development of neovascular complications in CRVO.

Attachment:





Skip Navigation Links
        صفحه اصلی
        ساختار کنگره
        تاریخ های مهم
        مکان برگزاری
        ثبت نام شدگان
        اطلاعات هتل - رزرو
        ارسال مقالات
        برنامه کنگره
        برنامه های جانبی
        نمایشگاه
        تماس با ما
        آرشیو کنگره سالهای گذشته
        جستجوی سخنران
 
Last News

  - بـیــست و سومین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران